Clinical Trials › NCT06167642

Enrolling by Invitation

Retinal Atrophy and Neurofilament Light Chain in People With Multiple Sclerosis Taking Ofatumumab

Sponsored by Johns Hopkins University

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.

View on ClinicalTrials.gov

75

Target enrollment

1

U.S. states

May 2023

Start date

Mar 2027

Expected completion

Interventions / Treatments

Ofatumumab

Conditions studied

Multiple Sclerosis

Where this trial is running (1 site)

Maryland1 site

Baltimore

Participating MS centers on MS Buddy (1)

Johns Hopkins Multiple Sclerosis Center
Baltimore, MD

MS centers in Maryland

Compare treatment centers near a trial site by center type, providers and trials.

View Maryland centers

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Get it on Google Play